Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer von Elshiaty, Mariam, Schindler, Hannah, Christopoulos, Petros

Volltext

Therapeutic Sequencing in ALK(+) NSCLC von Elsayed, Mei, Christopoulos, Petros

Volltext

Immune Modulation in Lung Cancer: Current Concepts and Future Strategies von Gaissmaier, Lena, Christopoulos, Petros

Volltext

Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis von Buchhalter, Ivo, Rempel, Eugen, Endris, Volker, Allgäuer, Michael, Neumann, Olaf, Volckmar, Anna‐Lena, Kirchner, Martina, Leichsenring, Jonas, Lier, Amelie, Winterfeld, Moritz, Penzel, Roland, Christopoulos, Petros, Thomas, Michael, Fröhling, Stefan, Schirmacher, Peter, Budczies, Jan, Stenzinger, Albrecht

Volltext

Breaking Bottlenecks for the TCR Therapy of Cancer von Gaissmaier, Lena, Elshiaty, Mariam, Christopoulos, Petros

Volltext

EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small cell lung cancer... von Christopoulos, Petros, Endris, Volker, Bozorgmehr, Farastuk, Elsayed, Mei, Kirchner, Martina, Ristau, Jonas, Buchhalter, Ivo, Penzel, Roland, Herth, Felix J., Heussel, Claus P., Eichhorn, Martin, Muley, Thomas, Meister, Michael, Fischer, Jürgen R., Rieken, Stefan, Warth, Arne, Bischoff, Helge, Schirmacher, Peter, Stenzinger, Albrecht, Thomas, Michael

Volltext

Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation von Christopoulos, Petros, Gaipl, Udo S

Volltext

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-a... von Faehling, Martin, Schumann, Christian, Christopoulos, Petros, Hoffknecht, Petra, Alt, Jürgen, Horn, Marlitt, Eisenmann, Stephan, Schlenska-Lange, Anke, Schütt, Philipp, Steger, Felix, Brückl, Wolfgang M., Christoph, Daniel C.

Volltext

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases von Volckmar, Anna‐Lena, Leichsenring, Jonas, Kirchner, Martina, Christopoulos, Petros, Neumann, Olaf, Budczies, Jan, Morais de Oliveira, Cristiano Manuel, Rempel, Eugen, Buchhalter, Ivo, Brandt, Regine, Allgäuer, Michael, Talla, Suranand Babu, von Winterfeld, Moritz, Herpel, Esther, Goeppert, Benjamin, Lier, Amelie, Winter, Hauke, Brummer, Tilman, Fröhling, Stefan, Faehling, Martin, Fischer, Jürgen R., Heußel, Claus Peter, Herth, Felix, Lasitschka, Felix, Schirmacher, Peter, Thomas, Michael, Endris, Volker, Penzel, Roland, Stenzinger, Albrecht

Volltext

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma von Budczies, Jan, Kirchner, Martina, Kluck, Klaus, Kazdal, Daniel, Glade, Julia, Allgäuer, Michael, Kriegsmann, Mark, Heußel, Claus-Peter, Herth, Felix J., Winter, Hauke, Meister, Michael, Muley, Thomas, Goldmann, Torsten, Fröhling, Stefan, Wermke, Martin, Waller, Cornelius F., Tufman, Amanda, Reck, Martin, Peters, Solange, Schirmacher, Peter, Thomas, Michael, Christopoulos, Petros, Stenzinger, Albrecht

Volltext

Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians von Allgäuer, Michael, Budczies, Jan, Christopoulos, Petros, Endris, Volker, Lier, Amelie, Rempel, Eugen, Volckmar, Anna-Lena, Kirchner, Martina, von Winterfeld, Moritz, Leichsenring, Jonas, Neumann, Olaf, Fröhling, Stefan, Penzel, Roland, Thomas, Michael, Schirmacher, Peter, Stenzinger, Albrecht

Volltext

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-... von Griesinger, Frank, Eberhardt, Wilfried, Nusch, Arnd, Reiser, Marcel, Zahn, Mark-Oliver, Maintz, Christoph, Bernhardt, Christiane, Losem, Christoph, Stenzinger, Albrecht, Heukamp, Lukas C., Büttner, Reinhard, Marschner, Norbert, Jänicke, Martina, Fleitz, Annette, Spring, Lisa, Sahlmann, Jörg, Karatas, Aysun, Hipper, Annette, Weichert, Wilko, Heilmann, Monika, Sadjadian, Parvis, Gleiber, Wolfgang, Grah, Christian, Waller, Cornelius F., Reck, Martin, Rittmeyer, Achim, Christopoulos, Petros, Sebastian, Martin, Thomas, Michael

Volltext

Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts von Kazdal, Daniel, Endris, Volker, Allgäuer, Michael, Kriegsmann, Mark, Leichsenring, Jonas, Volckmar, Anna-Lena, Harms, Alexander, Kirchner, Martina, Kriegsmann, Katharina, Neumann, Olaf, Brandt, Regine, Talla, Suranand B., Rempel, Eugen, Ploeger, Carolin, von Winterfeld, Moritz, Christopoulos, Petros, Merino, Diana M., Stewart, Mark, Allen, Jeff, Bischoff, Helge, Meister, Michael, Muley, Thomas, Herth, Felix, Penzel, Roland, Warth, Arne, Winter, Hauke, Fröhling, Stefan, Peters, Solange, Swanton, Charles, Thomas, Michael, Schirmacher, Peter, Budczies, Jan, Stenzinger, Albrecht

Volltext

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program von Frost, Nikolaj, Christopoulos, Petros, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jürgen, Gütz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian, Griesinger, Frank

Volltext

Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden von Budczies, Jan, Seidel, Anja, Christopoulos, Petros, Endris, Volker, Kloor, Matthias, Győrffy, Balázs, Seliger, Barbara, Schirmacher, Peter, Stenzinger, Albrecht, Denkert, Carsten

Volltext

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer von Daniello, Lea, Elshiaty, Mariam, Bozorgmehr, Farastuk, Kuon, Jonas, Kazdal, Daniel, Schindler, Hannah, Shah, Rajiv, Volckmar, Anna-Lena, Lusky, Fabienne, Diekmann, Leonore, Liersch, Stephan, Faehling, Martin, Muley, Thomas, Kriegsmann, Mark, Benesova, Karolina, Stenzinger, Albrecht, Thomas, Michael, Christopoulos, Petros

Volltext

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospec... von Kriegsmann, Katharina, Zgorzelski, Christiane, Muley, Thomas, Christopoulos, Petros, Thomas, Michael, Winter, Hauke, Eichhorn, Martin, Eichhorn, Florian, von Winterfeld, Moritz, Herpel, Esther, Goeppert, Benjamin, Stenzinger, Albrecht, Herth, Felix J. F., Warth, Arne, Kriegsmann, Mark

Volltext

A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma von Budczies, Jan, Kirchner, Martina, Kluck, Klaus, Kazdal, Daniel, Glade, Julia, Allgäuer, Michael, Kriegsmann, Mark, Heußel, Claus-Peter, Herth, Felix J., Winter, Hauke, Meister, Michael, Muley, Thomas, Fröhling, Stefan, Peters, Solange, Seliger, Barbara, Schirmacher, Peter, Thomas, Michael, Christopoulos, Petros, Stenzinger, Albrecht

Volltext

Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report von Christopoulos, Petros, Herster, Franziska, Hoffknecht, Petra, Falk, Markus, Tiemann, Markus, Kopp, Hans-Georg, Althoff, Andre, Stammberger, Anja, Laack, Eckart

Volltext

Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to f... von Bozorgmehr, Farastuk, Chung, Inn, Christopoulos, Petros, Krisam, Johannes, Schneider, Marc A, Brückner, Lena, Mueller, Daniel Wilhelm, Thomas, Michael, Rieken, Stefan

Volltext